Correction: Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis
- PMID: 27631606
- PMCID: PMC5025275
- DOI: 10.1371/journal.pone.0163386
Correction: Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0160064.].
Erratum for
-
Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.PLoS One. 2016 Aug 3;11(8):e0160064. doi: 10.1371/journal.pone.0160064. eCollection 2016. PLoS One. 2016. PMID: 27487187 Free PMC article.
References
-
- Cohen AT, Hamilton M, Bird A, Mitchell SA, Li S, Horblyuk R, et al. (2016) Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis. PLoS ONE 11(8): e0160064 doi: 10.1371/journal.pone.0160064 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
